1. Home
  2. IH vs CNTX Comparison

IH vs CNTX Comparison

Compare IH & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

SELL

Current Price

$1.19

Market Cap

58.8M

Sector

Real Estate

ML Signal

SELL

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$0.28

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
CNTX
Founded
1996
2015
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.8M
47.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
IH
CNTX
Price
$1.19
$0.28
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $4.03
AVG Volume (30 Days)
3.3K
★ 929.7K
Earning Date
09-29-2026
11-04-2026
Dividend Yield
★ 8.40%
N/A
EPS Growth
N/A
★ 17.39
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.30
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$0.27
52 Week High
$3.01
$3.62

Technical Indicators

Market Signals
Indicator
IH
CNTX
Relative Strength Index (RSI) 53.34 29.65
Support Level N/A N/A
Resistance Level $1.38 $0.36
Average True Range (ATR) 0.03 0.02
MACD 0.01 0.00
Stochastic Oscillator 60.00 4.29

Price Performance

Historical Comparison
IH
CNTX

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: